Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · IEX Real-Time Price · USD
40.00
+0.99 (2.54%)
At close: Apr 23, 2024, 4:00 PM
39.36
-0.64 (-1.60%)
After-hours: Apr 23, 2024, 5:38 PM EDT

Rhythm Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Net Income
-184.68-181.12-69.61-134-140.73-74.06-37.58-29.07-12
Depreciation & Amortization
1.761.671.160.690.830.440.220.140
Share-Based Compensation
32.5519.8320.817.4611.886.392.281.170.3
Other Operating Activities
14.21-13.81-98.35-6.135.275.185.621.344.02
Operating Cash Flow
-136.16-173.43-146-121.98-122.75-62.06-29.46-23.22-6.75
Capital Expenditures
-0.05-0.2899.57-0.21-3.39-0.72-0.13-1.06-0.02
Acquisitions
-5.6700000000
Change in Investments
0.0532.31-163.73158.75-24.59-86.43-109.91-4.050
Other Investing Activities
--42------
Investing Cash Flow
-5.6728.03-62.16158.53-27.97-87.15-110.04-5.11-0.02
Share Issuance / Repurchase
57.4141.49166.482.01163.47164.69126.3602.09
Debt Issued / Paid
24.3772.340000000
Other Financing Activities
-7.4-----40.84-39.62
Financing Cash Flow
74.37213.83166.482.01163.47164.69167.2041.71
Exchange Rate Effect
-0.1400000000
Net Cash Flow
-67.668.43-41.6838.5612.7515.4827.7-28.3334.94
Free Cash Flow
-136.2-173.71-46.44-122.19-126.14-62.78-29.59-24.28-6.77
Free Cash Flow Margin
-175.91%-734.87%-1472.32%------
Free Cash Flow Per Share
-2.36-3.33-0.94-2.77-3.46-2.02-2.23-2.38-0.66
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).